{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T09:20:38Z","timestamp":1700731238232},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00120-023-02063-y","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T11:04:48Z","timestamp":1681383888000},"page":"479-486","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["H\u00e4ufige Fehler, \u201ePitfalls\u201c und Komplikationsmanagement der Prostatabiopsie","Common errors, pitfalls, and management of complications of prostate biopsy"],"prefix":"10.1007","volume":"62","author":[{"given":"Benazir","family":"Enzinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Leonardo","family":"Pfitzinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Ebner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troya","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannic","family":"Volz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Apfelbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Kazmierczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Stief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Chaloupka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"issue":"16","key":"2063_CR1","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMms1914228","volume":"382","author":"HG Welch","year":"2020","unstructured":"Welch\u00a0HG, Albertsen\u00a0PC (2020) Reconsidering prostate cancer mortality\u2014the future of PSA screening. N\u00a0Engl J Med 382(16):1557\u20131563","journal-title":"N Engl J Med"},{"issue":"8472","key":"2063_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0140-6736(86)90715-4","volume":"1","author":"JE McNeal","year":"1986","unstructured":"McNeal\u00a0JE et\u00a0al (1986) Patterns of progression in prostate cancer. Lancet 1(8472):60\u201363","journal-title":"Lancet"},{"issue":"1","key":"2063_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/his.13712","volume":"74","author":"A Matoso","year":"2019","unstructured":"Matoso\u00a0A, Epstein\u00a0JI (2019) Defining clinically significant prostate cancer on the basis of pathological findings. Histopathology 74(1):135\u2013145","journal-title":"Histopathology"},{"issue":"24","key":"2063_CR4","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa1807801","volume":"379","author":"A Bill-Axelson","year":"2018","unstructured":"Bill-Axelson\u00a0A et al (2018) Radical prostatectomy or watchful waiting in prostate cancer\u201429-year follow-up. N\u00a0Engl J Med 379(24):2319\u20132329","journal-title":"N Engl J Med"},{"issue":"1","key":"2063_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","volume":"76","author":"J Hugosson","year":"2019","unstructured":"Hugosson\u00a0J et al (2019) A 16-yr follow-up of the European randomized study of screening for prostate cancer. Eur Urol 76(1):43\u201351","journal-title":"Eur Urol"},{"key":"2063_CR6","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022."},{"issue":"1","key":"2063_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.eururo.2017.01.033","volume":"72","author":"MJ Roobol","year":"2017","unstructured":"Roobol\u00a0MJ et\u00a0al (2017) Improving the Rotterdam European randomized study of screening for prostate cancer risk calculator for initial prostate biopsy by incorporating the 2014 international society of urological pathology Gleason grading and Cribriform growth. Eur Urol 72(1):45\u201351","journal-title":"Eur Urol"},{"key":"2063_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.urology.2017.04.015","volume":"105","author":"JS Jue","year":"2017","unstructured":"Jue\u00a0JS et al (2017) Re-examining prostate-specific antigen (PSA) density: defining the optimal PSA range and patients for using PSA density to predict prostate cancer using extended template biopsy. Urology 105:123\u2013128","journal-title":"Urology"},{"issue":"3","key":"2063_CR9","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.eururo.2022.03.003","volume":"82","author":"IM Wagensveld","year":"2022","unstructured":"Wagensveld\u00a0IM et al (2022) A prospective multicenter comparison study of risk-adapted ultrasound-directed and magnetic resonance imaging-directed diagnostic pathways for suspected prostate cancer in biopsy-na\u00efve men. Eur Urol 82(3):318\u2013326","journal-title":"Eur Urol"},{"issue":"2","key":"2063_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.euo.2018.02.010","volume":"1","author":"CK Mannaerts","year":"2018","unstructured":"Mannaerts\u00a0CK et al (2018) Prostate cancer risk assessment in biopsy-na\u00efve patients: the Rotterdam prostate cancer risk calculator in multiparametric magnetic resonance imaging-Transrectal ultrasound (TRUS) fusion biopsy and systematic TRUS biopsy. Eur Urol Oncol 1(2):109\u2013117","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"2063_CR11","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.euo.2019.08.015","volume":"3","author":"UG Falagario","year":"2020","unstructured":"Falagario\u00a0UG et al (2020) Avoiding unnecessary magnetic resonance imaging (MRI) and biopsies: negative and positive predictive value of MRI according to prostate-specific antigen density, 4Kscore and risk calculators. Eur Urol Oncol 3(5):700\u2013704","journal-title":"Eur Urol Oncol"},{"issue":"19","key":"2063_CR12","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan\u00a0V et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N\u00a0Engl J Med 378(19):1767\u20131777","journal-title":"N Engl J Med"},{"key":"2063_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012663.pub2","author":"FH Drost","year":"2019","unstructured":"Drost\u00a0FH et al (2019) Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD012663.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2063_CR14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2214\/AJR.20.23219","volume":"216","author":"R Cuocolo","year":"2021","unstructured":"Cuocolo\u00a0R et al (2021) Clinically significant prostate cancer detection with biparametric MRI: a systematic review and meta-analysis. AJR Am J Roentgenol 216(3):608\u2013621","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"2063_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2214\/AJR.18.20103","volume":"212","author":"Z Kang","year":"2019","unstructured":"Kang\u00a0Z et al (2019) Abbreviated biparametric versus standard multiparametric MRI for diagnosis of prostate cancer: a systematic review and meta-analysis. AJR Am J Roentgenol 212(2):357\u2013365","journal-title":"AJR Am J Roentgenol"},{"key":"2063_CR16","unstructured":"Deutsche Gesellschaft f\u00fcr Urologie (DGU). S3-Leitlinie Prostatakarzinom. Oktober 2021; Langversion 6.2.:[Available from: https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/Prostatatkarzinom\/Version_6\/LL_Prostatakarzinom_Langversion_6.2.pdf."},{"issue":"3","key":"2063_CR17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey\u00a0B et\u00a0al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76(3):340\u2013351","journal-title":"Eur Urol"},{"key":"2063_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.euros.2021.03.004","volume":"27","author":"HC Kang","year":"2021","unstructured":"Kang\u00a0HC et\u00a0al (2021) Accuracy of prostate magnetic resonance imaging: reader experience matters. Eur Urol Open Sci 27:53\u201360","journal-title":"Eur Urol Open Sci"},{"issue":"2","key":"2063_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/jmri.25372","volume":"45","author":"MD Greer","year":"2017","unstructured":"Greer\u00a0MD et\u00a0al (2017) Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: a multireader study. J\u00a0Magn Reson Imaging 45(2):579\u2013585","journal-title":"J Magn Reson Imaging"},{"issue":"7","key":"2063_CR20","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1007\/s00261-019-02302-x","volume":"45","author":"A Chatterjee","year":"2020","unstructured":"Chatterjee\u00a0A, Thomas\u00a0S, Oto\u00a0A (2020) Prostate MR: pitfalls and benign lesions. Abdom Radiol 45(7):2154\u20132164","journal-title":"Abdom Radiol"},{"issue":"7","key":"2063_CR21","first-page":"763","volume":"193","author":"T Franiel","year":"2021","unstructured":"Franiel\u00a0T et al (2021) mpMRI of the prostate (MR-Prostatography): updated recommendations of the DRG and BDR on patient preparation and scanning protocol. Rofo 193(7):763\u2013777","journal-title":"Rofo"},{"issue":"4","key":"2063_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/CH-209225","volume":"76","author":"M Apfelbeck","year":"2020","unstructured":"Apfelbeck\u00a0M et al (2020) Predictive clinical features for negative histopathology of MRI\/Ultrasound-fusion-guided prostate biopsy in patients with high likelihood of cancer at prostate MRI: Analysis from a\u00a0urologic outpatient clinic1. Clin Hemorheol Microcirc 76(4):503\u2013511","journal-title":"Clin Hemorheol Microcirc"},{"key":"2063_CR23","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3390\/cancers15041266","volume":"15","author":"M Chaloupka","year":"2023","unstructured":"Chaloupka\u00a0M et al (2023) Radical prostatectomy without prior biopsy in patients with high suspicion of prostate cancer based on multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography: a\u00a0prospective cohort study. Cancers 15:1266","journal-title":"Cancers"},{"issue":"9","key":"2063_CR24","doi-asserted-by":"publisher","first-page":"734.e19","DOI":"10.1016\/j.urolonc.2020.03.020","volume":"38","author":"KL Watts","year":"2020","unstructured":"Watts\u00a0KL et al (2020) Systematic review and meta-analysis comparing cognitive vs. image-guided fusion prostate biopsy for the detection of prostate cancer. Urol Oncol 38(9):734.e19\u2013734.e25","journal-title":"Urol Oncol"},{"issue":"10","key":"2063_CR25","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00120-022-01929-x","volume":"61","author":"A Sigle","year":"2022","unstructured":"Sigle\u00a0A et al (2022) Image-guided biopsy of the prostate gland. Urologie 61(10):1137\u20131148","journal-title":"Urologie"},{"issue":"4","key":"2063_CR26","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41391-019-0137-2","volume":"22","author":"D Halstuch","year":"2019","unstructured":"Halstuch\u00a0D et al (2019) Characterizing the learning curve of MRI-US fusion prostate biopsies. Prostate Cancer Prostatic Dis 22(4):546\u2013551","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2063_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.euros.2022.04.001","volume":"40","author":"MJ Hagens","year":"2022","unstructured":"Hagens\u00a0MJ et al (2022) Diagnostic performance of a\u00a0magnetic resonance imaging-directed targeted plus regional biopsy approach in prostate cancer diagnosis: a systematic review and meta-analysis. Eur Urol Open Sci 40:95\u2013103","journal-title":"Eur Urol Open Sci"},{"issue":"10","key":"2063_CR28","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1910038","volume":"382","author":"M Ahdoot","year":"2020","unstructured":"Ahdoot\u00a0M et al (2020) MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis. N\u00a0Engl J Med 382(10):917\u2013928","journal-title":"N Engl J Med"},{"issue":"3","key":"2063_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/MOU.0b013e328329a33e","volume":"19","author":"AR Patel","year":"2009","unstructured":"Patel\u00a0AR, Jones\u00a0JS (2009) Optimal biopsy strategies for the diagnosis and staging of prostate cancer. Curr Opin Urol 19(3):232\u2013237","journal-title":"Curr Opin Urol"},{"issue":"3","key":"2063_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.eururo.2022.01.008","volume":"82","author":"WG Brisbane","year":"2022","unstructured":"Brisbane\u00a0WG et\u00a0al (2022) Targeted prostate biopsy: umbra, penumbra, and value of perilesional sampling. Eur Urol 82(3):303\u2013310","journal-title":"Eur Urol"},{"issue":"12","key":"2063_CR31","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/00000478-198812000-00001","volume":"12","author":"JE McNeal","year":"1988","unstructured":"McNeal\u00a0JE et\u00a0al (1988) Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12(12):897\u2013906","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2063_CR32","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.eururo.2016.12.006","volume":"71","author":"MG Schouten","year":"2017","unstructured":"Schouten\u00a0MG et al (2017) Why and where do we miss significant prostate cancer with multi-parametric magnetic resonance imaging followed by magnetic resonance-guided and Transrectal ultrasound-guided biopsy in biopsy-na\u00efve men? Eur Urol 71(6):896\u2013903","journal-title":"Eur Urol"},{"issue":"7","key":"2063_CR33","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/j.1464-410X.2012.10972.x","volume":"110","author":"NJ Mabjeesh","year":"2012","unstructured":"Mabjeesh\u00a0NJ et al (2012) High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy. BJU Int 110(7):993\u2013997","journal-title":"BJU Int"},{"issue":"5","key":"2063_CR34","doi-asserted-by":"publisher","first-page":"e860","DOI":"10.1016\/j.clgc.2019.05.006","volume":"17","author":"X Tu","year":"2019","unstructured":"Tu\u00a0X et al (2019) Transperineal magnetic resonance imaging-targeted biopsy May perform better than transrectal route in the detection of clinically significant prostate cancer: systematic review and meta-analysis. Clin Genitourin Cancer 17(5):e860\u2013e870","journal-title":"Clin Genitourin Cancer"},{"issue":"8","key":"2063_CR35","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1017\/S0950268815002885","volume":"144","author":"HY Bennett","year":"2016","unstructured":"Bennett\u00a0HY et\u00a0al (2016) The global burden of major infectious complications following prostate biopsy. Epidemiol Infect 144(8):1784\u20131791","journal-title":"Epidemiol Infect"},{"issue":"3","key":"2063_CR36","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.eururo.2012.06.003","volume":"63","author":"FM Wagenlehner","year":"2013","unstructured":"Wagenlehner\u00a0FM et\u00a0al (2013) Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a\u00a0prospective multinational multicentre prostate biopsy study. Eur Urol 63(3):521\u2013527","journal-title":"Eur Urol"},{"issue":"11","key":"2063_CR37","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s00345-020-03112-3","volume":"38","author":"O Derin","year":"2020","unstructured":"Derin\u00a0O et\u00a0al (2020) Infectious complications of prostate biopsy: winning battles but not war. World J Urol 38(11):2743\u20132753","journal-title":"World J Urol"},{"issue":"2","key":"2063_CR38","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/JU.0000000000000814","volume":"204","author":"A Pilatz","year":"2020","unstructured":"Pilatz\u00a0A et al (2020) Antibiotic prophylaxis for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis. J\u00a0Urol 204(2):224\u2013230","journal-title":"J Urol"},{"issue":"6","key":"2063_CR39","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.eururo.2011.12.058","volume":"61","author":"S Loeb","year":"2012","unstructured":"Loeb\u00a0S et\u00a0al (2012) Infectious complications and hospital admissions after prostate biopsy in a\u00a0European randomized trial. Eur Urol 61(6):1110\u20131114","journal-title":"Eur Urol"},{"key":"2063_CR40","doi-asserted-by":"publisher","first-page":"976273","DOI":"10.1155\/2012\/976273","volume":"2012","author":"A Dalhoff","year":"2012","unstructured":"Dalhoff\u00a0A (2012) Global fluoroquinolone resistance epidemiology and implictions for clinical use. Interdiscip Perspect Infect Dis 2012:976273","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"2063_CR41","unstructured":"Rote-Hand-Brief zu Fosfuro 3000mg."},{"issue":"4","key":"2063_CR42","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.juro.2010.11.088","volume":"185","author":"MA Liss","year":"2011","unstructured":"Liss\u00a0MA et\u00a0al (2011) Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J\u00a0Urol 185(4):1283\u20131288","journal-title":"J Urol"},{"issue":"3","key":"2063_CR43","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/JU.0000000000001399","volume":"205","author":"B Pradere","year":"2021","unstructured":"Pradere\u00a0B et al (2021) Nonantibiotic strategies for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis. J\u00a0Urol 205(3):653\u2013663","journal-title":"J Urol"},{"issue":"6","key":"2063_CR44","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","volume":"64","author":"S Loeb","year":"2013","unstructured":"Loeb\u00a0S et\u00a0al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64(6):876\u2013892","journal-title":"Eur Urol"},{"issue":"5","key":"2063_CR45","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0090-4295(02)01958-1","volume":"60","author":"R Raaijmakers","year":"2002","unstructured":"Raaijmakers\u00a0R et al (2002) Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a\u00a0population-based screening program. Urology 60(5):826\u2013830","journal-title":"Urology"},{"issue":"4","key":"2063_CR46","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.purol.2019.12.006","volume":"30","author":"E Sefik","year":"2020","unstructured":"Sefik\u00a0E et al (2020) The effect of alpha blocker treatment prior to prostate biopsy on voiding functions, pain scores and health-related quality-of-life outcomes: A prospective randomized trial. Prog Urol 30(4):198\u2013204","journal-title":"Prog Urol"},{"issue":"3","key":"2063_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/sj.pcan.4500955","volume":"10","author":"M Manoharan","year":"2007","unstructured":"Manoharan\u00a0M et al (2007) Hemospermia following transrectal ultrasound-guided prostate biopsy: a\u00a0prospective study. Prostate Cancer Prostatic Dis 10(3):283\u2013287","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"2063_CR48","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s11255-007-9175-0","volume":"39","author":"KP Braun","year":"2007","unstructured":"Braun\u00a0KP et\u00a0al (2007) Endoscopic therapy of a\u00a0massive rectal bleeding after prostate biopsy. Int Urol Nephrol 39(4):1125\u20131129","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"2063_CR49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/sj.pcan.4500935","volume":"10","author":"HY Tiong","year":"2007","unstructured":"Tiong\u00a0HY et al (2007) A meta-analysis of local anesthesia for transrectal ultrasound-guided biopsy of the prostate. Prostate Cancer Prostatic Dis 10(2):127\u2013136","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"2063_CR50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/00365590701514555","volume":"42","author":"U Tekdogan","year":"2008","unstructured":"Tekdogan\u00a0U et\u00a0al (2008) Is the pain level of patients affected by anxiety during transrectal prostate needle biopsy? Scand J Urol Nephrol 42(1):24\u201328","journal-title":"Scand J Urol Nephrol"},{"issue":"9-10","key":"2063_CR51","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1159\/000517275","volume":"105","author":"JN Mumm","year":"2021","unstructured":"Mumm\u00a0JN et al (2021) Listening to music during outpatient cystoscopy reduces pain and anxiety and increases satisfaction: results from a\u00a0prospective randomized study. Urol Int 105(9-10):792\u2013798","journal-title":"Urol Int"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-023-02063-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-023-02063-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-023-02063-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T08:04:36Z","timestamp":1683187476000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-023-02063-y"}},"subtitle":["Die h\u00e4ufigsten diagnostischen und prozeduralen Herausforderungen der transrektalen Fusionsbiopsie der Prostata bei Erstdiagnose eines klinisch signifikanten Prostatakarzinoms","The most common diagnostic and procedural challenges of transrectal fusion prostate biopsy in the initial diagnosis of clinically significant prostate cancer"],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["2063"],"URL":"https:\/\/doi.org\/10.1007\/s00120-023-02063-y","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"16 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"B.\u00a0Enzinger, P.L.\u00a0Pfitzinger, B.\u00a0Ebner, T.\u00a0Ivanova, Y.\u00a0Volz, M.\u00a0Apfelbeck, P.\u00a0Kazmierczak, C.\u00a0Stief und M.\u00a0Chaloupka geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}